UB Paderborn / Katalog / Suche / in CDI

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Journal of thrombosis and haemostasis, 2006-04, Vol.4 (4), p.766-773

2006

Link zum Volltext

Verfügbarkeit prüfen

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

Journal of thrombosis and haemostasis, 2008-05, Vol.6 (5), p.762-771

2008

Link zum Volltext

Verfügbarkeit prüfen

Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging

Transplant international, 2012-02, Vol.25 (2), p.250-260

2012

Link zum Volltext

Verfügbarkeit prüfen

Lipasin/betatrophin is differentially expressed in liver and white adipose tissue without association with insulin resistance in Wistar and Goto-Kakizaki rats

Physiological research, 2017-01, Vol.66 (2), p.273-281

2017

Link zum Volltext

Verfügbarkeit prüfen

Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

Journal of thrombosis and haemostasis, 2006-04, Vol.4 (4), p.774-782

2006

Link zum Volltext

Verfügbarkeit prüfen

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1304-1312

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1VWD)

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.715-721

2007

Link zum Volltext

Verfügbarkeit prüfen

Thirty‐four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.773-781

2003

Link zum Volltext

Verfügbarkeit prüfen

Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe hemophilia A in the Czech Republic

Journal of thrombosis and haemostasis, 2003-06, Vol.1 (6), p.1323-1324

2003

Link zum Volltext

Verfügbarkeit prüfen

New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors

Časopis lékařů českých, 2006, Vol.145 (2), p.104-111

Habart, D

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular diagnosis of haemophilia A in clinical practice

Časopis lékařů českých, 2005, Vol.144 (12), p.795-800

Habart, D

2005

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathogenesis of haemophilia A

Časopis lékařů českých, 2005, Vol.144 (11), p.727-732

Habart, D

2005

Link zum Volltext

Verfügbarkeit prüfen

Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination

Prenatal diagnosis, 2003-03, Vol.23 (3), p.235-238

2003

Link zum Volltext

Verfügbarkeit prüfen

Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging: MRI prediction of pancreatic islet rejection

Transplant international, 2012-02, Vol.25 (2), p.250-260

2012

Link zum Volltext

Verfügbarkeit prüfen

von Willebrand disease type 2N (Normandy)

Vnitřní lékar̆stvĭ, 2003-04, Vol.49 (4), p.253

Habart, D

2003

Link zum Volltext

Verfügbarkeit prüfen

Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe haemophilia A in the Czech Republic

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P0637-P0637

2003

Link zum Volltext

Verfügbarkeit prüfen

The anti-thrombin variant −6Arg is a silent mutation

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P1566-P1566

2003

Link zum Volltext

Verfügbarkeit prüfen

A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P0648-P0648

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of DHPLC analysis for mutation detection in haemophilia A

Časopis lékařů českých, 2006, Vol.145 (6), p.484-487

2006

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous and Semi-Automated Evaluation of Three Variable Tandem Repeats within von Willebrand Factor Gene by Capillary Electrophoresis with Multicolour Fluorescent Detection

Acta haematologica, 2003-01, Vol.110 (1), p.41-42

2003

Link zum Volltext

Verfügbarkeit prüfen

Laboratory tests for precise classification and genetic analysis of von Willebrand disease

Sbornik lekarsky, 2003, Vol.104 (2), p.237

2003

Link zum Volltext

Verfügbarkeit prüfen

Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A

Transfusion and apheresis science, 2004-08, Vol.31 (1), p.75-77

2004

Link zum Volltext

Verfügbarkeit prüfen

Genetic databases. Though we were not the first ones, at least let us not to be the last

Časopis lékařů českých, 2006, Vol.145 (12), p.897-900

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular study of type 2 von Willebrand disease

Časopis lékařů českých, 2003, Vol.142 (6), p.373

2003

Link zum Volltext

Verfügbarkeit prüfen

Molecular basis of hereditary antithrombin defects in 10 Czech families

Časopis lékařů českých, 2000-09, Vol.139 (19), p.596

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging

Lipasin/betatrophin is differentially expressed in liver and white adipose tissue without association with insulin resistance in Wistar and Goto-Kakizaki rats

Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1VWD)

Thirty‐four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions

Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe hemophilia A in the Czech Republic

New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors

Molecular diagnosis of haemophilia A in clinical practice

Molecular pathogenesis of haemophilia A

Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination

Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging: MRI prediction of pancreatic islet rejection

von Willebrand disease type 2N (Normandy)

Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe haemophilia A in the Czech Republic

The anti-thrombin variant −6Arg is a silent mutation

A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A

Evaluation of DHPLC analysis for mutation detection in haemophilia A

Simultaneous and Semi-Automated Evaluation of Three Variable Tandem Repeats within von Willebrand Factor Gene by Capillary Electrophoresis with Multicolour Fluorescent Detection

Laboratory tests for precise classification and genetic analysis of von Willebrand disease

Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A

Genetic databases. Though we were not the first ones, at least let us not to be the last

Molecular study of type 2 von Willebrand disease

Molecular basis of hereditary antithrombin defects in 10 Czech families

Suchergebnisse filtern